Tech Company Financing Transactions

Verge Genomics Funding Round

Threshold Ventures, Agent Capital and ALS Investment Fund participated in a $32 million Series A capital raise for Verge Genomics. The funding round was announced on 7/17/2018.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Software

Mailing Address

42A Dore St.
San Francisco, CA 94103
USA

Phone

Undisclosed

Website

www.vergegenomics.com

Email Address

[email protected]

Overview

Neurological diseases are caused by complex interactions between many genes. Many drug discoveries fail because researchers target only one gene at a time. We use machine learning to find new drugs faster and more cheaply.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Alice Zhang

        

Co-Founder

Jason Chen

        

VP - Operations

Lucia Huang

        

Browse more venture capital transactions:

Prev: 7/17/2018: Inventys venture capital transaction
Next: 7/17/2018: Univercells SA venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to document all VC transactions involving tech companies. VC transactions reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary